Vongpatanasin W, Brickner M E, Hillis L D, Lange R A
University of Texas Southwestern Medical Center, Dallas, USA.
Ann Intern Med. 1998 May 1;128(9):745-55. doi: 10.7326/0003-4819-128-9-199805010-00008.
For this article, the literature on the pathophysiology, clinical features, natural history, prognosis, and management of the Eisenmenger syndrome in adults was reviewed. English-language articles from 1966 to the present were identified through a search of the MEDLINE database by using the terms Eisenmenger, congenital heart disease, and pulmonary hypertension. Selected cross-referenced articles were also included. Articles on the pathophysiology, clinical presentation, evaluation, natural history, complications, and treatment of the Eisenmenger syndrome in adults were selected, and descriptive and analytical data relevant to the practicing physician were manually extracted. The Eisenmenger syndrome is characterized by elevated pulmonary vascular resistance and right-to-left shunting of blood through a systemic-to-pulmonary circulation connection. Most patients with the syndrome survive for 20 to 30 years. The hemostatic changes associated with the syndrome may lead to thromboembolic events, cerebrovascular complications, or the hyperviscosity syndrome. Erythrocytosis is present in most patients, but excessive phlebotomy may cause microcytosis and exacerbate the symptoms of hyperviscosity. Other complications associated with the Eisenmenger syndrome include hemoptysis, gout, cholelithiasis, hypertrophic osteoarthropathy, and decreased renal function. Pregnancy or noncardiac surgery is associated with a high mortality rate in patients with the Eisenmenger syndrome. Because most pediatric patients with the Eisenmenger syndrome survive to adulthood, primary care physicians should have a thorough understanding of the syndrome; its associated complications; and medical and surgical management, especially with regard to the appropriate timing of phlebotomy and lung or heart-lung transplantation. In addition, patients with the syndrome should undergo routine follow-up at a tertiary care center that has physicians and nurses with special expertise in congenital heart disease. In patients with the Eisenmenger syndrome who are pregnant or require noncardiac surgery, a multidisciplinary approach should be used to reduce the excessive mortality associated with these conditions.
本文对成人艾森曼格综合征的病理生理学、临床特征、自然病史、预后及治疗方面的文献进行了综述。通过使用“艾森曼格”“先天性心脏病”和“肺动脉高压”等检索词,在MEDLINE数据库中检索了1966年至今的英文文献。还纳入了选定的交叉引用文章。选取了关于成人艾森曼格综合征的病理生理学、临床表现、评估、自然病史、并发症及治疗的文章,并人工提取了与执业医师相关的描述性和分析性数据。艾森曼格综合征的特征是肺血管阻力升高以及血液通过体循环至肺循环的连接从右向左分流。大多数该综合征患者可存活20至30年。与该综合征相关的止血变化可能导致血栓栓塞事件、脑血管并发症或高黏滞综合征。大多数患者存在红细胞增多症,但过度放血可能导致小红细胞症并加重高黏滞症状。与艾森曼格综合征相关的其他并发症包括咯血、痛风、胆石症、肥厚性骨关节病及肾功能减退。艾森曼格综合征患者妊娠或进行非心脏手术时死亡率很高。由于大多数患有艾森曼格综合征的儿科患者可存活至成年,初级保健医生应全面了解该综合征及其相关并发症以及药物和手术治疗,尤其是放血及肺或心肺移植的合适时机。此外,该综合征患者应在有先天性心脏病专科医生和护士的三级医疗中心进行常规随访。对于妊娠或需要进行非心脏手术的艾森曼格综合征患者,应采用多学科方法以降低与这些情况相关的过高死亡率。